Precursors / Bristol Myer-Squibb Pharmaceuticals
Bristol Myer-Squibb Pharmaceuticals
Cited as Princeton, NJ, USA
- Syntheses citing them
- 1
- Distinct agents
- 1
- Distinct precursors
- 1
From the literature
Precursors named in the literature
Names as written by the authors. Grade, packaging and current availability are not published and have to be confirmed with the supplier.
Where they were used
| Agent | Precursor | Module | Purification | Source |
|---|---|---|---|---|
| [11C]ibrutinib | 3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-2,3-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-amine | TracerMaker | HPLC+SPE | 39355638 2021 Front Nucl Med |
From the manufacturer
No manufacturer-submitted profile yet. Everything above comes from published papers, not from Bristol Myer-Squibb Pharmaceuticals itself.
Need this precursor?We can point you to suppliers for Bristol Myer-Squibb Pharmaceuticals, or handle the enquiry for you.
Get in touch